RT @MHIF_Heart: MHIF Researcher, Dr Santiago Garcia is lead author in this paper @JACCJournals ! #PRESERVE https://t.co/Byl3dSm2NU
RT @MHIF_Heart: MHIF Researcher, Dr Santiago Garcia is lead author in this paper @JACCJournals ! #PRESERVE https://t.co/Byl3dSm2NU
RT @MHIF_Heart: MHIF Researcher, Dr Santiago Garcia is lead author in this paper @JACCJournals ! #PRESERVE https://t.co/Byl3dSm2NU
RT @MHIF_Heart: MHIF Researcher, Dr Santiago Garcia is lead author in this paper @JACCJournals ! #PRESERVE https://t.co/Byl3dSm2NU
MHIF Researcher, Dr Santiago Garcia is lead author in this paper @JACCJournals ! #PRESERVE
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @drfherediaz: INTERESANTE. PERO TAMPICO LA EMPEIRÓ. VERDAD? https://t.co/XuLAQrdPp8
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
INTERESANTE. PERO TAMPICO LA EMPEIRÓ. VERDAD?
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
RT @JonathanNefro: Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni d…
Con ENFERMEDAD RENAL CRÓNICA, en las INTERVENCIONES PERCUTANEAS CORONARIAS no se encontró beneficio de BICARBONATO, ni de N-Acetyl-Cisteina en la prevención de NEFROPATÍA por CONTRASTE, MUERTE o necesitar DIÁLISIS. 🤷🏻♂️ JACC: 11, NO. 22, 2018:2254–61 htt
RT @epinephstats: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https…
Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://t.co/L56Q7zSDzb
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @bernardowise: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @bernardowise: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @bernardowise: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @bernardowise: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adverse 90-day events or contrast-associated acute kidney injury compared to placebo #CardioTwitter https://t.co/D9nJplvLcq
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
#CIN - an important issue cardiologists have to deal with, published in @JACCJournals - and still no promising way to reduce it. Need to keep on saving contrast media in pts. with impaired kidney function.
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
RT @JACCJournals: PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adve…
PRESERVE sub-group analysis: Neither IV sodium bicarbonate nor oral acetylcysteine were superior in reducing serious adverse 90-day events or contrast-associated acute kidney injury compared to placebo: https://t.co/yBSOrXfgA0. #JACCINT https://t.co/xBAY7R
RT @krychtiukmd: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @krychtiukmd: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just…
RT @sccccardio: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the preventio…
Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevention of contrast-associated acute kidney injury? Sub-group analysis of PRESERVE demonstrates no benefit over placebo: https://t.co/pszRr
RT @krychtiukmd: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just…
RT @krychtiukmd: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just…
RT @krychtiukmd: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just…
RT @krychtiukmd: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just…
RT @krychtiukmd: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just…
Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention just sit back and relax? @JACCJournals @DLBHATTMD #Cardiology #cardiotwitter @JGrapsa @MihaiTrofenciuc @ALEX_MISCHIE @drdargaray https:/
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
Still I see many specialist prescribing NAC for prevention of CAAKI. Sometime better than nothing ! @divyaa24 @tukaramj @Pankaj22839055 @kshitzo @abdagirenitin @hswapnil @nikhil01063 @drkirannarang @piyush_jul02
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
😏
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
RT @JACCJournals: Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevent…
Among patients w/ CKD undergoing PCI, should IV sodium bicarbonate or oral acetylcysteine be administered for the prevention of contrast-associated acute kidney injury? Sub-group analysis of PRESERVE demonstrates no benefit over placebo: https://t.co/1B3gf
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…
RT @DLBHATTMD: Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes Following Percutaneous Coronary Intervention https://…